Follow
Jingyu Peng
Jingyu Peng
Research Fellow, Dana Farber Cancer Institute, Harvard Medical School
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR–Cas9 library
S Zhu, W Li, J Liu, CH Chen, Q Liao, P Xu, H Xu, T Xiao, Z Cao, J Peng, ...
Nature biotechnology 34 (12), 1279-1286, 2016
4832016
High‐throughput screens in mammalian cells using the CRISPR‐Cas9 system
J Peng, Y Zhou, S Zhu, W Wei
The FEBS journal 282 (11), 2089-2096, 2015
892015
Divergent roles of BECN1 in LC3 lipidation and autophagosomal function
R He, J Peng, P Yuan, F Xu, W Wei
Autophagy 11 (5), 740-747, 2015
762015
A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma
S Pal, JP Kaplan, H Nguyen, SA Stopka, MR Savani, MS Regan, ...
Cancer Cell 40 (9), 957-972. e10, 2022
472022
Deciphering essential cistromes using genome-wide CRISPR screens
T Fei, W Li, J Peng, T Xiao, CH Chen, A Wu, J Huang, C Zang, XS Liu, ...
Proceedings of the National Academy of Sciences 116 (50), 25186-25195, 2019
412019
Glucosyltransferase Activity of Clostridium difficile Toxin B Triggers Autophagy-mediated Cell Growth Arrest
R He, J Peng, P Yuan, J Yang, X Wu, Y Wang, W Wei
Scientific reports 7 (1), 10532, 2017
92017
Divergent roles of BECN1 in LC3 lipidation and autophagosomal function (vol 11, pg 740, 2019)
R He, J Peng, P Yuan, F Xu, W Wei
AUTOPHAGY 16 (4), 777-778, 2020
2020
Speaker 2: Wensheng Wei, China
S Zhu, Y Zhou, P Yuan, J Peng, S Guo, Q Li, J Liu, Z Cao, W Wei
International Journal of Neuropsychopharmacology 19 (Suppl 1), 16, 2016
2016
CRISPR screening in the study of human disease
W Wei, S Zhu, Y Zhou, P Yuan, J Peng, S Guo, Q Li, J Liu, Z Cao
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 19, 16-16, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–9